Search Results
Updates on bispecific T cell engagers (BiTEs) for the treatment of acute lymphoblastic leukaemia
Bispecific T-Cell Engagers (BiTEs) as Treatment of B-Cell Lymphoma
Updates on BiTEs for B-ALL
Trials of BiTEs for the treatment of acute leukemias
Seminar 7: Bispecific T-cell Engagers (BiTEs) in Myeloma
Recent advances in ALL treatment
BiTES for the treatment of acute myeloid leukemia (AML) - results with AMG 330 in ex vivo study
Safety profile of BiTE therapy
An update on AMG 330: can BiTEs be as successful in AML as ALL?
An update on the state-of-affairs of BiTEs in the world of AML
The value of bispecific T-cell engager therapies in myeloma & future considerations for these agents
Harnessing T-cells in acute leukemia and an anti-CD33/CD3 BiTE antibody
